🇺🇸 FDA

Drug profile · INN

potassium citrate

SIBNAYAL

approved A12BA30
US status
approved
Patents linked
1
News articles
0

Quick answer

potassium citrate (SIBNAYAL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN potassium citrate
Brand SIBNAYAL
Route ORAL
Formulation FOR SOLUTION
ATC code A12BA30

Related patents

Search patents →

Frequently asked questions

What is potassium citrate?

potassium citrate (SIBNAYAL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for potassium citrate?

SIBNAYAL is a marketed brand name for potassium citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of potassium citrate?

potassium citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.